Sigma-Aldrich, Sangamo Expand Zinc Finger Tech License

The firms have expanded a licensing deal, granting Sigma-Aldrich rights to use the technology for the commercial production of protein pharmaceuticals.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories